Dec 02, 2022

Identifying trends and at-risk demographics among gynecologic oncology doctors regarding wellness and burnout is important for planning future interventions. The results of the 2020 Society of Gynecol...

Dec 01, 2022

For a study, researchers sought to determine if obese individuals who have planned cesarean deliveries under neuraxial anesthesia were more likely to experience umbilical artery pH less than 7.1 and b...

Dec 01, 2022

For a study, researchers sought to assess the obstetric and neonatal outcomes of the first live birth delivered 1 or more years after receiving a breast cancer diagnosis. In a population-based anal...

Dec 01, 2022

Once-daily relugolix combination therapy was well tolerated and reduced menstrual blood loss volume and pain in women with heavy menstrual bleeding associated with uterine leiomyomas in the LIBERTY 1 ...

Nov 30, 2022

Fibroblasts were extracted from samples of EOC to use as a primary source. For this purpose, researchers obtained expression profiles from microdissection and single-cell RNA sequencing (scRNA-seq) da...

Nov 30, 2022

The most deadly gynecologic cancer is epithelial ovarian cancer (EOC). Before surgery and during follow-up after therapy, researchers investigated whether circulating tumor DNA (ctDNA) could be a usef...

Nov 30, 2022

Biomarkers and treatment options for advanced and recurring illnesses are scarce. Although the mechanism of action of bevacizumab, an anti-angiogenesis medication, is uncertain, endometrial malignanci...

Nov 29, 2022

For a study, the aim was to find out what role increased CRABP2 expression plays in the development and progression of endometrial cancer (EC). Using a decision tree classifier, patients were divided ...

Nov 29, 2022

When compared to high grade serous ovarian cancer (HGSOC), low grade serous ovarian cancer (LGSOC) has distinct etiology, molecular, genetic, and clinical features. Limited testing, inconsistent histo...

Nov 29, 2022

Due to insufficient early detection methods, ovarian cancer remains a leading cause of death among gynecological malignancies. Therefore, DNA methylation profiling in blood samples was investigated fo...

Nov 28, 2022

Uterine serous carcinoma (USC) has HER2 as a major therapeutic and prognostic target. However, there is a lack of consensus on the best HER2 testing infrastructure, and testing recommendations have ev...

Nov 28, 2022

Complications following cytoreductive surgery for Stage III or IV epithelial ovarian cancer with or without splenectomy are described, and opportunities for better post-splenectomy treatment are highl...

Nov 28, 2022

For a study, it is essential to analyze the postoperative and oncologic results of pelvic exenteration for non-ovarian gynecologic cancers. From January 1, 2010, through December 31, 2019, researchers...

Nov 25, 2022

Cytoreductive surgery (CRS) feasibility and the need for extensive surgery in patients with advanced ovarian cancer are difficult to assess. Therefore, it will be helpful to identify patients for CRS ...

Nov 25, 2022

Ovarian cancer patients who report a higher level of patient-centered communication (PCC) have a higher health-related quality of life (HRQoL). TThe quantitative metrics of PCC and HRQoL does not well...

Nov 25, 2022

This study aimed to evaluate the feasibility and acceptability of a web-based patient reported outcome (PRO) program for persons with advanced ovarian cancer using electronic self-assessment and care ...

Nov 24, 2022

Goal: to assess toxicity, quality of life, and progression-free survival (PFS) in patients with advanced ovarian cancer who underwent neoadjuvant chemotherapy (NAC) followed by CRS and HIPEC with carb...

Nov 24, 2022

A double-blind, randomized, placebo-controlled, phase 2 trial compared gemcitabine in combination with the WEE1 inhibitor adavosertib or placebo in patients with platinum-resistant or refractory high-...

Nov 24, 2022

The most common type of ovarian cancer, high-grade serous ovarian cancer, has a dismal prognosis, and new treatments are desperately needed for individuals with platinum-resistant or -refractory disea...

Nov 23, 2022

Among patients with early-stage high-risk epithelial ovarian cancer, researchers sought to evaluate the use of a clinical calculator in redefining prognosis and the need for treatment. Information on ...